Wall Street analysts expect that National Health Investors Inc (NYSE:NHI) will post $74.22 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for National Health Investors’ earnings. The highest sales estimate is $74.55 million and the lowest is $73.86 million. National Health Investors reported sales of $71.35 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 4%. The company is expected to issue its next earnings results on Wednesday, November 14th.

On average, analysts expect that National Health Investors will report full year sales of $295.33 million for the current financial year, with estimates ranging from $294.20 million to $297.00 million. For the next year, analysts anticipate that the business will report sales of $313.02 million per share, with estimates ranging from $296.69 million to $322.41 million. Zacks’ sales averages are a mean average based on a survey of research analysts that cover National Health Investors.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, August 7th. The real estate investment trust reported $0.91 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.96 by ($0.05). National Health Investors had a net margin of 53.16% and a return on equity of 11.49%. The company had revenue of $72.96 million during the quarter, compared to analyst estimates of $73.80 million.

NHI has been the subject of a number of recent analyst reports. Capital One Financial upgraded National Health Investors from an “equal weight” rating to an “overweight” rating in a research report on Friday, May 11th. Stifel Nicolaus set a $83.00 price target on National Health Investors and gave the company a “buy” rating in a research report on Tuesday, August 7th. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Wednesday, July 25th. Cantor Fitzgerald reiterated a “neutral” rating on shares of National Health Investors in a research report on Wednesday, May 16th. Finally, SunTrust Banks reiterated a “hold” rating and issued a $79.00 price target on shares of National Health Investors in a research report on Wednesday, August 8th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. National Health Investors currently has an average rating of “Hold” and a consensus target price of $75.44.

Shares of NYSE:NHI traded up $0.38 during midday trading on Thursday, reaching $78.94. The company had a trading volume of 109,468 shares, compared to its average volume of 215,903. The company has a quick ratio of 15.56, a current ratio of 15.56 and a debt-to-equity ratio of 0.90. National Health Investors has a 1-year low of $62.71 and a 1-year high of $81.60. The firm has a market capitalization of $3.22 billion, a price-to-earnings ratio of 14.81, a price-to-earnings-growth ratio of 3.30 and a beta of 0.43.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 9th. Investors of record on Friday, September 28th will be paid a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 5.07%. The ex-dividend date of this dividend is Thursday, September 27th. National Health Investors’s dividend payout ratio is currently 75.05%.

A number of institutional investors have recently made changes to their positions in NHI. Principal Financial Group Inc. lifted its stake in National Health Investors by 7,076.6% in the 1st quarter. Principal Financial Group Inc. now owns 506,594 shares of the real estate investment trust’s stock worth $34,089,000 after acquiring an additional 499,535 shares in the last quarter. BlackRock Inc. lifted its stake in National Health Investors by 4.7% in the 2nd quarter. BlackRock Inc. now owns 4,026,546 shares of the real estate investment trust’s stock worth $296,676,000 after acquiring an additional 182,378 shares in the last quarter. Hamlin Capital Management LLC lifted its stake in National Health Investors by 39.8% in the 2nd quarter. Hamlin Capital Management LLC now owns 625,250 shares of the real estate investment trust’s stock worth $46,068,000 after acquiring an additional 178,110 shares in the last quarter. Bank of America Corp DE lifted its stake in National Health Investors by 34.4% in the 2nd quarter. Bank of America Corp DE now owns 478,340 shares of the real estate investment trust’s stock worth $35,245,000 after acquiring an additional 122,484 shares in the last quarter. Finally, LSV Asset Management lifted its stake in National Health Investors by 37.9% in the 2nd quarter. LSV Asset Management now owns 410,248 shares of the real estate investment trust’s stock worth $30,227,000 after acquiring an additional 112,648 shares in the last quarter. 70.67% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More: Outstanding Shares, Buying and Selling Stocks

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.